Overview
Halcinonide is a corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses, and is distributed as a cream and ointment. Halcinonide is marketed under the brand name Halog® by Ranbaxy Laboratories Inc. Research suggests that clobetasol propionate demonstrates superior pharmacologic efficacy in the treatment of psoriasis when compared to halcinonide.
Indication
Indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.
Associated Conditions
- Dermatosis
- Corticosteroid-responsive dermatoses
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|
No clinical trials found
No clinical trials found for this drug
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries, Inc. | 10631-094 | TOPICAL | 1 mg in 1 g | 1/7/2019 | |
| Glasshouse Pharmaceuticals Limited Canada | 71428-011 | TOPICAL | 1 mg in 1 g | 1/9/2024 | |
| Sun Pharmaceutical Industries, Inc. | 10631-096 | TOPICAL | 1 mg in 1 g | 7/29/2019 | |
| Sun Pharmaceutical Industries, Inc. | 10631-095 | TOPICAL | 1 mg in 1 mL | 5/18/2021 | |
| Mylan Pharmaceuticals Inc. | 0378-8056 | TOPICAL | 1 mg in 1 g | 8/30/2019 | |
| Sun Pharmaceutical Industries, Inc. | 57664-698 | TOPICAL | 1 mg in 1 g | 5/27/2021 |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| No NMPA approvals found for this drug. | |||||
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||
Health Canada Drug Approvals
Approved Product | Company | DIN | Dosage Form | Strength | Market Date |
|---|---|---|---|---|---|
| HALOG ONT 0.1% | bristol-myers squibb canada | 02010283 | Ointment - Topical | 0.1 % | 12/31/1977 |
| HALOG CREAM 0.1% | bristol-myers squibb canada | 02011921 | Cream - Topical | 0.1 % | 12/31/1994 |
| HALOG LIQ 0.1% | westwood-squibb, division of bristol-myers squibb canada inc. | 02010291 | Liquid - Topical | .1 % | 12/31/1972 |
CIMA AEMPS Drug Approvals
Approved Product | Company | Registration Number | Pharmaceutical Form | Prescription Type | Status |
|---|---|---|---|---|---|
| No CIMA AEMPS (Spain) approvals found for this drug. | |||||
Philippines FDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Philippines FDA approvals found for this drug. | |||||
Saudi SFDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Saudi SFDA approvals found for this drug. | |||||
Malaysia NPRA Drug Approvals
Approved Product | Company | Registration Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Malaysia NPRA approvals found for this drug. | |||||
UK EMC Drug Information
Medicine Name | MA Holder | MA Number | Pharmaceutical Form | Active Ingredient | Authorization Date |
|---|---|---|---|---|---|
| No UK EMC drug information found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.